Kardigan rises in Nasdaq debut after upsized $400 million IPO

Kardigan Inc., a biotech company specializing in heart-health, saw its shares rise nearly 2% during its Nasdaq trading debut. This increase follows the company's initial public offering, which was upsized to raise a total of $400 million. The stock's positive movement occurred immediately after the IPO, reflecting the market's initial reaction to the heart-health focused firm's entry into the public exchange and its successful capital raise of $400 million.